Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and ‘Ajanta’s Code of Conduct for Insiders’, Ajanta Pharma has informed that the Trading Window for dealing in securities of the Company shall remain closed from Thursday, 1st October 2026 till 48 hours after the declaration of Financial Results of the Company for the second quarter and half year ended 30th September 2026.
The above information is a part of company’s filings submitted to BSE.